Skip to main content

Table 1 Demographic and Clinical Characteristics at the Time of Diagnosis

From: Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study

Variables Total (n = 46)
Male 24 (52.2)
Age (years) 58.2 ± 13.6 [20.4–82.1]
Duration of symptoms before diagnosis (years) 1.5 ± 2.3 [0–12.1]
Presenting symptoms  
 Cough and sputum > 3 months 23 (50.0)
 Hemoptysis 2 (4.3)
 Single respiratory tract infection 14 (30.4)
 Recurrent bronchitis 16 (34.8)
 Recurrent pneumonia 9 (19.6)
 Incidental 3 (6.5)
Interval between first renal transplantation and first symptoms (years) 9.1 ± 7.3 (0.2–25.3)
Interval between first renal transplantation and diagnosis (years) 10.9 ± 7.5 (0.4–32.0)
Cause of end-stage renal disease  
 Chronic glomerulonephritis 10 (21.7)
 Diabetic nephropathy 0 (0)
 Autosomal dominant polycystic kidney disease 15 (32.6)
 Chronic tubulointerstitial nephritis 11 (23.9)
 Unknown cause of end-stage renal disease 4 (8.7)
 Other renal disease 6 (13.0)
Age at the first renal transplantation (years) 47.3 ± 15.1 [9.4–72.9]
Number of renal transplantations  
 One renal transplantation 41 (89.1)
 Two renal transplantations 4 (8.7)
 Three renal transplantations 1 (2.2)
Immunosuppressive regimen  
 Induction therapy  
  Anti-lymphocyte globulins 21 (45.7)
  Basiliximab 8 (17.4)
 Steroids 46 (100)
 Purine synthesis inhibitor  
  Mycophenolic acid (MPA) 43 (93.5)
  Azathioprine 14 (30.4)
 Calcineurin inhibitors  
  Cyclosporine 32 (69.6)
  Tacrolimus 15 (32.5)
 mTOR inhibitors  
  Sirolimus 12 (26.1)
  Everolimus 1 (2.2)
 Rituximab 1 (2.2)
  1. Data are expressed as frequency (percentage) or mean ± standard deviation [minimum, maximum]